<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27124046</article-id>
      <article-id pub-id-type="pmc">4998709</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000003479</article-id>
      <article-id pub-id-type="art-access-id">03479</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4500</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary Malignant Melanoma of the Esophagus With Unusual Endoscopic Findings</article-title>
        <subtitle>A Case Report and Literature Review</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Hui</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yan</surname>
            <given-names>Yan</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Chun-Meng</given-names>
          </name>
          <degrees>PhD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Girelli.</surname>
            <given-names>Carlo</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Gastroenterology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.</aff>
      <author-notes>
        <corresp>Correspondence: Chun-Meng Jiang, Department of Gastroenterology, The Second Affiliated Hospital of Dalian Medical University, No. 467 Zhongshan Road, Shahekou Region, Dalian, Liaoning 116023, China (e-mail: <email>jcmydey@sina.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>17</issue>
      <elocation-id>e3479</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e3479.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Primary malignant melanoma of the esophagus (PMME) is a rare disease with an extremely poor prognosis. We experienced a 79-year-old man with PMME who had unusual endoscopic findings. On endoscopy, an elongated lump was detected on 1 side of the vertical axis of the esophagus. The mass extended progressively for 15&#x200A;cm along the esophageal longitudinal axis and invaded half of the esophageal circumference. These endoscopic findings were not characteristic of PMME, and the condition was confirmed with biopsy and immunohistochemical staining. Here, we present this rare case and review the recent relevant literature regarding PMME. Doctors should be aware that PMME might present with unusual endoscopic findings.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Primary malignant melanoma of the esophagus (PMME) is an extremely rare but highly aggressive tumor that accounts for 0.1% to 0.5% of all primary esophageal malignancies.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The mean survival time from diagnosis is only 13.4 months, and the 5-year survival rate is 4.2%.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> A definitive diagnosis may be obtained with pathological analysis and identification of positivity for S-100 and human melanoma black (HMB)-45 on immunohistochemical examination. Surgical extirpation is the standard treatment for PMME. Here, we present a case of PMME with unusual endoscopic findings in a Chinese male and review the relevant literature.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 79-year-old man was referred to our department because of progressive dysphagia and weight loss for 1 month. Computed tomography performed at a local hospital identified an esophageal tumor; thus, he was admitted to our hospital. He had hematemesis, melena, fever, cough, and yellow sputum. Blood analysis indicated severe anemia and high leukocyte and neutrophil levels. Additionally, the albumin level was very low, and a sputum smear revealed the presence of gram-positive cocci. On endoscopy, an elongated lump was detected on 1 side of the vertical axis of the esophagus approximately 25 to 40&#x200A;cm away from the incisors. The mass extended progressively for 15&#x200A;cm along the esophageal longitudinal axis and invaded half of the esophageal circumference. Additionally, the mass had extensive necrotic tissue, active hemorrhage spots, and no pigmentation on the surface (Figure <xref ref-type="fig" rid="F1">1</xref>A&#x2013;C). Biopsy was performed, and the tumor was identified as a malignant melanoma (Figure <xref ref-type="fig" rid="F2">2</xref>). On immunohistochemical staining, the tumor was positive for S-100 and HMB-45 (Figure <xref ref-type="fig" rid="F3">3</xref>A and B) and negative for cytokeratin and carcinoembryonic antigen markers. Computed tomography showed inflammation of the lungs and no evidence of distant metastasis. Additionally, a physical examination revealed no pigmented lesions at the skin, eyes, rectum, or other locations. Surgery, chemotherapy, or radiotherapy could not be performed owing to the advanced age of the patient and comorbid hypoproteinemia, infection, and severe anemia. Therefore, the patient did not receive treatment and was discharged. After approximately 1 month, we were informed of his death.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>A&#x2013;C presented the endoscopic images of the primary malignant melanoma of the esophagus from different perspectives. Figure <xref ref-type="fig" rid="F1">1</xref> A indicated that there was no pigmentation on the surface. Figure <xref ref-type="fig" rid="F1">1</xref> B and C presented that the mass extended progressively for 15&#x200A;cm along the esophageal longitudinal axis and invaded half of the esophageal circumference. Figure <xref ref-type="fig" rid="F1">1</xref> C indicated that the mass had extensive necrotic tissue, active hemorrhage spots and no pigmentation on the surface.</p>
        </caption>
        <graphic xlink:href="medi-95-e3479-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Histopathological staining (hematoxylin and eosin staining) shows the presence of melanin granules.</p>
        </caption>
        <graphic xlink:href="medi-95-e3479-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Immunohistochemical staining shows the presence of human melanoma black (HMB)-45 (A) and S100 (B) in the tumor cells. HMB = human melanoma black.</p>
        </caption>
        <graphic xlink:href="medi-95-e3479-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>PMME is generally considered to be a highly malignant tumor that is associated with a poor prognosis and a rapidly fatal course. The mean patient age at onset is 60.5 years. The incidence of PMME has been reported to be higher in male patients than in female patients, with a ratio of 2:1.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> The mean survival time from diagnosis has been reported to be 13.4 months.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> There are 6 reports of patients surviving more than 7 years,<sup><xref rid="R3" ref-type="bibr">3</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref></sup> and the longest survival time is 12 years.<sup><xref rid="R8" ref-type="bibr">8</xref></sup></p>
      <p>The tumor is sporadic, and the number of reported cases is small, with only 337 reported cases up to 2011.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> In a recently published series of 910 esophageal biopsies in Japan, only 2 were found to be melanoma (0.2%).<sup><xref rid="R10" ref-type="bibr">10</xref></sup></p>
      <p>The majority of PMME patients present with complaints of dysphagia, nonspecific retrosternal pain, and weight loss. Hematemesis and melena are observed occasionally. A typical finding of PMME is a lobular or polypoid, well-circumscribed, and pigmented tumor. In addition, more than 90% of PMME lesions are located in the distal 2/3 of the esophagus.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> The tumor is most often polypoid, and the nonpolypoid form, identified in the present case, is extremely rare. Approximately 10% to 25% of PMME cases present various colors, such as purple, brown, and white, depending on the melanin quantity.<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> The tumor in the present case was 15&#x200A;cm in length, invaded 1 side of the esophagus, and had no melanin pigmentation on the surface. These findings are not characteristic of PMME. Although tissue pathology identified the presence of melanin granules, the tumor did not have a typical black appearance. We performed immunohistological studies to obtain an accurate diagnosis. On immunohistochemical analysis, the tumor was positive for HMB-45 and S-100. Therefore, we diagnosed the tumor as a malignant melanoma. The diagnosis of PMME is based on the finding of melanin granules in the tumor cells on histological examination, as the clinical and radiological features of PMME are similar to those of other esophageal malignancies. Histological diagnosis can be challenging when the biopsy specimen lacks melanin granules, and the tumor might be incorrectly diagnosed as an epithelial carcinoma. Therefore, when melanin granules cannot be identified in the initial biopsy, immunohistochemical analysis of the biopsy specimen for melanocytic-specific markers, such as HMB-45, S-100, and melanoma-specific antigen (Melan-A), should be performed to obtain an accurate pretreatment diagnosis.</p>
      <p>There is a lack of consensus on the treatment of PMME. Cheung et al<sup><xref rid="R14" ref-type="bibr">14</xref></sup> found that complete surgical resection was the only treatment strategy that significantly improved survival in PMME patients. Other therapies include chemotherapy, chemoradiotherapy, endocrine therapy, and immunotherapy. However, the roles of these treatment strategies remain unclear. A previous study showed that they might benefit in loco-regional disease control.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Completely nonsurgical treatment strategies have been reported sporadically<sup><xref rid="R16" ref-type="bibr">16</xref></sup>; however, most of the patients who successfully received these treatments also underwent surgery.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R16" ref-type="bibr">16</xref>&#x2013;<xref rid="R19" ref-type="bibr">19</xref></sup></p>
      <p>Molecular analysis could identify targets for additional specific therapy. Mutations in the <italic>BRAF</italic> and <italic>KIT</italic> genes in subsets of melanoma have been reported. Langer et al<sup><xref rid="R20" ref-type="bibr">20</xref></sup> detected a mutation of the <italic>c-KIT</italic> gene in 2 patients with PMME. BRAF inhibitors may be useful in the treatment of metastatic melanoma in patients with <italic>BRAF</italic> mutations. However, in patients with PMME, its efficacy has not been proven.<sup><xref rid="R21" ref-type="bibr">21</xref></sup></p>
      <p>The prognosis of PMME is poor because the tumor has a highly aggressive biological behavior and most patients are diagnosed late. Early diagnosis with complete surgical resection currently offers the best chance of survival.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSION</title>
      <p>We reported an extremely rare case of PMME with unusual endoscopic findings. The tumor was diagnosed according to histological and immunohistochemical analyses. Doctors should be aware that PMME might present with unusual endoscopic findings.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: HMB = human melanoma black, Melan-A = melanoma-specific antigen, PMME = primary malignant melanoma of the esophagus</p>
      </fn>
      <fn fn-type="other">
        <p>Written informed consent was obtained from the patient's family for publication of this case report and any accompanying images.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabanathan</surname><given-names>S</given-names></name><name><surname>Eng</surname><given-names>J</given-names></name><name><surname>Pradhan</surname><given-names>GN</given-names></name></person-group>
<article-title>Primary malignant melanoma of the esophagus</article-title>. <source><italic>Am J Gastroenterol</italic></source>
<year>1989</year>; <volume>84</volume>:<fpage>1475</fpage>&#x2013;<lpage>1481</lpage>.<pub-id pub-id-type="pmid">2688398</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalkiadakis</surname><given-names>G</given-names></name><name><surname>Wihlm</surname><given-names>JM</given-names></name><name><surname>Morand</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus</article-title>. <source><italic>Ann Thorac Surg</italic></source>
<year>1985</year>; <volume>39</volume>:<fpage>472</fpage>&#x2013;<lpage>475</lpage>.<pub-id pub-id-type="pmid">3994450</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabat</surname><given-names>J</given-names></name><name><surname>Mannan</surname><given-names>R</given-names></name><name><surname>Legasto</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Long-term survivor of primary malignant melanoma of the esophagus treated with surgical resection</article-title>. <source><italic>Int J Surg Case Rep</italic></source>
<year>2015</year>; <volume>6C</volume>:<fpage>182</fpage>&#x2013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">25543881</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uetsuka</surname><given-names>H</given-names></name><name><surname>Naomoto</surname><given-names>Y</given-names></name><name><surname>Fujiwara</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus: long-term survival following pre- and postoperative adjuvant hormone/chemotherapy</article-title>. <source><italic>Dig Dis Sci</italic></source>
<year>2004</year>; <volume>49</volume>:<fpage>1646</fpage>&#x2013;<lpage>1651</lpage>.<pub-id pub-id-type="pmid">15573920</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawada</surname><given-names>K</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival</article-title>. <source><italic>Gastrointest Endosc</italic></source>
<year>2007</year>; <volume>66</volume>:<fpage>408</fpage>&#x2013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">17643724</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoury-Helou</surname><given-names>A</given-names></name><name><surname>Lozac&#x2019;h</surname><given-names>C</given-names></name><name><surname>Vandenbrouke</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus</article-title>. <source><italic>Ann Chir</italic></source>
<year>2001</year>; <volume>126</volume>:<fpage>557</fpage>&#x2013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">11486540</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itami</surname><given-names>A</given-names></name><name><surname>Tomokazu</surname><given-names>M</given-names></name><name><surname>Yutaka</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>A case of primary malignant melanoma of the esophagus with long-term survival</article-title>. <source><italic>Esophagus</italic></source>
<year>2004</year>; <volume>1</volume>:<fpage>135</fpage>&#x2013;<lpage>137</lpage>.</mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdy</surname><given-names>FC</given-names></name><name><surname>Smith</surname><given-names>JH</given-names></name><name><surname>Kennedy</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Long survival after excision of a primary malignant melanoma of the oesophagus</article-title>. <source><italic>Thorax</italic></source>
<year>1991</year>; <volume>46</volume>:<fpage>397</fpage>&#x2013;<lpage>398</lpage>.<pub-id pub-id-type="pmid">2068703</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisceglia</surname><given-names>M</given-names></name><name><surname>Perri</surname><given-names>F</given-names></name><name><surname>Tucci</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review</article-title>. <source><italic>Adv Anat Pathol</italic></source>
<year>2011</year>; <volume>18</volume>:<fpage>235</fpage>&#x2013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">21490441</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>T</given-names></name></person-group>
<article-title>A clinicopathologic study of esophageal 860 benign and malignant lesions in 910 cases of consecutive esophageal biopsies</article-title>. <source><italic>Int J Clin Exp Pathol</italic></source>
<year>2013</year>; <volume>6</volume>:<fpage>191</fpage>&#x2013;<lpage>198</lpage>.<pub-id pub-id-type="pmid">23330004</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>AA</given-names></name><name><surname>Wu</surname><given-names>TT</given-names></name><name><surname>Prieto</surname><given-names>VG</given-names></name><etal/></person-group>
<article-title>Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases</article-title>. <source><italic>Arch Pathol Lab Med</italic></source>
<year>2008</year>; <volume>132</volume>:<fpage>1623</fpage>&#x2013;<lpage>1629</lpage>.<pub-id pub-id-type="pmid">18834221</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Sakuramachi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Amelanotic malignant melanoma of the esophagus: case report and review of the literature</article-title>. <source><italic>Jpn J Clinoncol</italic></source>
<year>1990</year>; <volume>20</volume>:<fpage>286</fpage>&#x2013;<lpage>295</lpage>.</mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joob</surname><given-names>AW</given-names></name><name><surname>Haines</surname><given-names>GK</given-names></name><name><surname>Kies</surname><given-names>MS</given-names><suffix>III</suffix></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus</article-title>. <source><italic>Ann Thorac Surg</italic></source>
<year>1995</year>; <volume>60</volume>:<fpage>217</fpage>&#x2013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">7598604</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>MC</given-names></name><name><surname>Perez</surname><given-names>EA</given-names></name><name><surname>Molina</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Defining the role of surgery for primary gastrointestinal tract melanoma</article-title>. <source><italic>J Gastrointest Surg</italic></source>
<year>2008</year>; <volume>12</volume>:<fpage>731</fpage>&#x2013;<lpage>738</lpage>.<pub-id pub-id-type="pmid">18058185</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mihajlovic</surname><given-names>M</given-names></name><name><surname>Vlajkovic</surname><given-names>S</given-names></name><name><surname>Jovanovic</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Primary mucosal melanomas: a comprehensive review</article-title>. <source><italic>Int J Clin Exp Pathol</italic></source>
<year>2012</year>; <volume>5</volume>:<fpage>739</fpage>&#x2013;<lpage>753</lpage>.<pub-id pub-id-type="pmid">23071856</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulshof</surname><given-names>MC</given-names></name><name><surname>Van Haaren</surname><given-names>PM</given-names></name><name><surname>Zum V&#xF6;rde Sive V&#xF6;rding</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus</article-title>. <source><italic>Dis Esophagus</italic></source>
<year>2010</year>; <volume>23</volume>:<fpage>E42</fpage>&#x2013;<lpage>E47</lpage>.<pub-id pub-id-type="pmid">21040149</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naomoto</surname><given-names>Y</given-names></name><name><surname>Perdomo</surname><given-names>JA</given-names></name><name><surname>Kamikawa</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus: report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy</article-title>. <source><italic>Jpn J Clin Oncol</italic></source>
<year>1998</year>; <volume>28</volume>:<fpage>758</fpage>&#x2013;<lpage>761</lpage>.<pub-id pub-id-type="pmid">9879295</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asakage</surname><given-names>M</given-names></name><name><surname>Kitayama</surname><given-names>J</given-names></name><name><surname>Tsuno</surname><given-names>NH</given-names></name><etal/></person-group>
<article-title>Primary malignant melanoma of the esophagus treated by esophagectomy and adjuvant dendritic-cell therapy</article-title>. <source><italic>J Gastroenterol</italic></source>
<year>2005</year>; <volume>40</volume>:<fpage>545</fpage>&#x2013;<lpage>546</lpage>.<pub-id pub-id-type="pmid">15942723</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides</article-title>. <source><italic>Jpn J Clin Oncol</italic></source>
<year>2007</year>; <volume>37</volume>:<fpage>140</fpage>&#x2013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">17255158</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langer</surname><given-names>R</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Feith</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases</article-title>. <source><italic>Mod Pathol</italic></source>
<year>2011</year>; <volume>24</volume>:<fpage>495</fpage>&#x2013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">21131919</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>PB</given-names></name><name><surname>Hauschild</surname><given-names>A</given-names></name><name><surname>Robert</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Improved survival with vemurafenib in melanoma with BRAF V600E mutation</article-title>. <source><italic>N Engl J Med</italic></source>
<year>2011</year>; <volume>364</volume>:<fpage>2507</fpage>&#x2013;<lpage>2516</lpage>.<pub-id pub-id-type="pmid">21639808</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
